MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS

Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ANTONOV, DMITRY, LINDSTROEM, MATS STEFAN, KAHNBERG, PIA CECILIA, ROSENQUIST, ASA ANNICA, DE KOCK, HERMAN, SAMUELSSON, BENGT BERTIL, RABOISSON, PIERRE, NILSSON, KARL MAGNUS, SIMMEN, KENNETH
Format: Patent
Sprache:ger
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ANTONOV, DMITRY
LINDSTROEM, MATS STEFAN
KAHNBERG, PIA CECILIA
ROSENQUIST, ASA ANNICA
DE KOCK, HERMAN
SAMUELSSON, BENGT BERTIL
RABOISSON, PIERRE
NILSSON, KARL MAGNUS
SIMMEN, KENNETH
description Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE496934TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE496934TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE496934TT13</originalsourceid><addsrcrecordid>eNrjZDDwdfQO8neOdPbxDHb2cFXw9PPwdPIM8Q9y9VNwcQ1W8HANcAzxDPEM1nXWDfMMCg3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxjiGuJpZmlsYmISGGxsSoAQBX5yco</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS</title><source>esp@cenet</source><creator>ANTONOV, DMITRY ; LINDSTROEM, MATS STEFAN ; KAHNBERG, PIA CECILIA ; ROSENQUIST, ASA ANNICA ; DE KOCK, HERMAN ; SAMUELSSON, BENGT BERTIL ; RABOISSON, PIERRE ; NILSSON, KARL MAGNUS ; SIMMEN, KENNETH</creator><creatorcontrib>ANTONOV, DMITRY ; LINDSTROEM, MATS STEFAN ; KAHNBERG, PIA CECILIA ; ROSENQUIST, ASA ANNICA ; DE KOCK, HERMAN ; SAMUELSSON, BENGT BERTIL ; RABOISSON, PIERRE ; NILSSON, KARL MAGNUS ; SIMMEN, KENNETH</creatorcontrib><description>Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.</description><language>ger</language><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110215&amp;DB=EPODOC&amp;CC=AT&amp;NR=E496934T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20110215&amp;DB=EPODOC&amp;CC=AT&amp;NR=E496934T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ANTONOV, DMITRY</creatorcontrib><creatorcontrib>LINDSTROEM, MATS STEFAN</creatorcontrib><creatorcontrib>KAHNBERG, PIA CECILIA</creatorcontrib><creatorcontrib>ROSENQUIST, ASA ANNICA</creatorcontrib><creatorcontrib>DE KOCK, HERMAN</creatorcontrib><creatorcontrib>SAMUELSSON, BENGT BERTIL</creatorcontrib><creatorcontrib>RABOISSON, PIERRE</creatorcontrib><creatorcontrib>NILSSON, KARL MAGNUS</creatorcontrib><creatorcontrib>SIMMEN, KENNETH</creatorcontrib><title>MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS</title><description>Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDwdfQO8neOdPbxDHb2cFXw9PPwdPIM8Q9y9VNwcQ1W8HANcAzxDPEM1nXWDfMMCg3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxjiGuJpZmlsYmISGGxsSoAQBX5yco</recordid><startdate>20110215</startdate><enddate>20110215</enddate><creator>ANTONOV, DMITRY</creator><creator>LINDSTROEM, MATS STEFAN</creator><creator>KAHNBERG, PIA CECILIA</creator><creator>ROSENQUIST, ASA ANNICA</creator><creator>DE KOCK, HERMAN</creator><creator>SAMUELSSON, BENGT BERTIL</creator><creator>RABOISSON, PIERRE</creator><creator>NILSSON, KARL MAGNUS</creator><creator>SIMMEN, KENNETH</creator><scope>EVB</scope></search><sort><creationdate>20110215</creationdate><title>MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS</title><author>ANTONOV, DMITRY ; LINDSTROEM, MATS STEFAN ; KAHNBERG, PIA CECILIA ; ROSENQUIST, ASA ANNICA ; DE KOCK, HERMAN ; SAMUELSSON, BENGT BERTIL ; RABOISSON, PIERRE ; NILSSON, KARL MAGNUS ; SIMMEN, KENNETH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE496934TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2011</creationdate><toplevel>online_resources</toplevel><creatorcontrib>ANTONOV, DMITRY</creatorcontrib><creatorcontrib>LINDSTROEM, MATS STEFAN</creatorcontrib><creatorcontrib>KAHNBERG, PIA CECILIA</creatorcontrib><creatorcontrib>ROSENQUIST, ASA ANNICA</creatorcontrib><creatorcontrib>DE KOCK, HERMAN</creatorcontrib><creatorcontrib>SAMUELSSON, BENGT BERTIL</creatorcontrib><creatorcontrib>RABOISSON, PIERRE</creatorcontrib><creatorcontrib>NILSSON, KARL MAGNUS</creatorcontrib><creatorcontrib>SIMMEN, KENNETH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ANTONOV, DMITRY</au><au>LINDSTROEM, MATS STEFAN</au><au>KAHNBERG, PIA CECILIA</au><au>ROSENQUIST, ASA ANNICA</au><au>DE KOCK, HERMAN</au><au>SAMUELSSON, BENGT BERTIL</au><au>RABOISSON, PIERRE</au><au>NILSSON, KARL MAGNUS</au><au>SIMMEN, KENNETH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS</title><date>2011-02-15</date><risdate>2011</risdate><abstract>Inhibitors of HCV of formula (I). and the N-oxides, salts, and stereoisomers thereof, wherein the dashed line represents an optional double bond between atoms C7 and C8; R1 is hydrogen or C1-6alkyl; R2 is hydrogen or C1-6alkyl; and n is 3, 4, 5, or 6; pharmaceutical compositions containing compounds (I) and processes for preparing compounds (I) are provided. Bioavailable combinations of the inhibitors of HCV of formula (I) with ritonavir are also provided.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ger
recordid cdi_epo_espacenet_ATE496934TT1
source esp@cenet
title MAKROCYCLISCHE INHIBITOREN DES HEPATITIS-C-VIRUS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T07%3A00%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ANTONOV,%20DMITRY&rft.date=2011-02-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE496934TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true